Genetic and epigenetic risk factors for diabetic kidney disease

Advances in Chronic Kidney Disease

Volumn 21, Issue 3, 2014, Pages 287-296

  McKnight, Amy Jayne ^a   McKay, Gareth J ^a   Maxwell, Alexander P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Diabetic; Epigenetic; Genetic; Kidney; Meta analysis

Indexed keywords

ARTICLE; DIABETES MELLITUS; DIABETIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA METHYLATION; EPIGENETICS; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETICS; HISTONE MODIFICATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; RNA INTERFERENCE; DIABETIC NEPHROPATHIES; EPIDEMIOLOGY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION;

DIABETIC NEPHROPATHIES; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS;

EID: 84899571795     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.03.010     Document Type: Review

References (84)

1. Marshall S.M. Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?. Diabetologia 2012, 55(9):2301-2306.
2. Williams W.W., Salem R.M., McKnight A.J., et al. Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes 2012, 61(8):2187-2194.
3. Fox C.S., Matsushita K., Woodward M., et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012, 380(9854):1662-1673.
4. International Diabetes Federation IDF Diabetes Atlas 2014, International Diabetes Federation, Brussels, Belgium. 6th ed.
5. Patterson C.C., Dahlquist G.G., Gyurus E., Green A., Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009, 373(9680):2027-2033.
6. Zhang P., Zhang X., Brown J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87(3):293-301.
7. Canani L.H., Gerchman F., Gross J.L. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 1999, 48(4):909-913.
8. Spray B.J., Atassi N.G., Tuttle A.B., Freedman B.I. Familial risk, age at onset, and cause of end-stage renal disease in white Americans. JAm Soc Nephrol 1995, 5(10):1806-1810.
9. U.S.Renal Data System International comparisons. USRDS 2013 Annual Data Report: Atlas of End-Stage Renal Disease in the United States 2013, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
10. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329(14):977-986.
11. Krolewski M., Eggers P.W., Warram J.H. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 1996, 50(6):2041-2046.
12. Fogarty D.G., Hanna L.S., Wantman M., et al. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 2000, 49(6):1057-1063.
13. Fogarty D.G., Rich S.S., Hanna L., Warram J.H., Krolewski A.S. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int 2000, 57(1):250-257.
14. Forsblom C.M., Kanninen T., Lehtovirta M., Saloranta C., Groop L.C. Heritability of albumin excretion rate in families of patients with Type II diabetes. Diabetologia 1999, 42(11):1359-1366.
15. Langefeld C.D., Beck S.R., Bowden D.W., et al. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 2004, 43(5):796-800.
16. McKnight A.J., O'Donoghue D., Peter M.A. Annotated chromosome maps for renal disease. Hum Mutat 2009, 30(3):314-320.
17. McKnight A.J., Currie D., Maxwell A.P. Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders. JPathol 2010, 220(2):198-216.
18. Pezzolesi M.G., Krolewski A.S. The genetic risk of kidney disease in type 2 diabetes. Med Clin North Am 2013, 97(1):91-107.
19. Thameem F., Igo R.P., Freedman B.I., et al. A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the family investigation of nephropathy and diabetes (FIND). PLoS One 2013, 8(12):e81888.
20. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273(5281):1516-1517.
21. Chan Y., Lim E., Sandholm N., et al. An excess of risk-increasing low frequency variants can be a signal of polygenic inheritance in complex diseases. Am J Hum Genet 2014, 94(3):437-452.
22. Sandholm N., Salem R.M., McKnight A.J., et al. New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet 2012, 8(9):e1002921.
23. Sandholm N., Forsblom C., Makinen V.P., et al. Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes. Diabetologia 2014 Mar 5, [Epub ahead of print]. doi:10.1007/s00125-014-3202-3.
24. Little J., Higgins J.P., Ioannidis J.P., et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 2009, 6(2):e22.
25. Shimazaki A., Kawamura Y., Kanazawa A., et al. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 2005, 54(4):1171-1178.
26. Hanson R.L., Millis M.P., Young N.J., et al. ELMO1 variants and susceptibility to diabetic nephropathy in American Indians. Mol Genet Metab 2010, 101(4):383-390.
27. Leak T.S., Perlegas P.S., Smith S.G., et al. Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann Hum Genet 2009, 73(2):152-159.
28. Pezzolesi M.G., Katavetin P., Kure M., et al. Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes 2009, 58(11):2698-2702.
29. Wu H.Y., Wang Y., Chen M., et al. Association of ELMO1 gene polymorphisms with diabetic nephropathy in Chinese population. J Endocrinol Invest 2013, 36(5):298-302.
30. Yadav A.K., Kumar V., Dutta P., Bhansali A., Jha V. Variations in CCR5, but not HFE, ELMO1, SLC12A3, are associated with susceptibility to kidney disease in North Indian subjects with type 2 diabetes. JDiabetes 2014 Jan 17, [Epub ahead of print]. doi:10.1111/1753-0407.12152.
31. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316(5829):1331-1336.
32. Todd J.A., Walker N.M., Cooper J.D., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39(7):857-864.
33. Zeggini E., Weedon M.N., Lindgren C.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316(5829):1336-1341.
34. Hanson R.L., Craig D.W., Millis M.P., et al. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 2007, 56(4):975-983.
35. McDonough C.W., Palmer N.D., Hicks P.J., et al. A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 2011, 79(5):563-572.
36. Franceschini N., Shara N.M., Wang H., et al. The association of genetic variants of type 2 diabetes with kidney function. Kidney Int 2012, 82(2):220-225.
37. McKnight A.J., Maxwell A.P., Sawcer S., et al. A genome-wide DNA microsatellite association screen to identify chromosomal regions harboring candidate genes in diabetic nephropathy. J Am Soc Nephrol 2006, 17(3):831-836.
38. Pezzolesi M.G., Poznik G.D., Mychaleckyj J.C., et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 2009, 58(6):1403-1410.
39. Craig D.W., Millis M.P., DiStefano J.K. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes. Diabet Med 2009, 26(11):1090-1098.
40. Pluzhnikov A., Below J.E., Konkashbaev A., et al. Spoiling the whole bunch: quality control aimed at preserving the integrity of high-throughput genotyping. Am J Hum Genet 2010, 87(1):123-128.
41. Veikkolainen V., Naillat F., Railo A., et al. ErbB4 modulates tubular cell polarity and lumen diameter during kidney development. JAm Soc Nephrol 2012, 23(1):112-122.
42. Cooke Bailey J.N., Palmer N.D., Ng M.C., et al. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans. Hum Genet 2014, 9(3):366-376.
43. Sandholm N., McKnight A.J., Salem R.M., et al. Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes. J Am Soc Nephrol 2013, 24(10):1537-1543.
44. Brennan E.P., Morine M.J., Walsh D.W., et al. Next-generation sequencing identifies TGF-beta1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy. Biochim Biophys Acta 2012, 1822(4):589-599.
45. Kelly K.J., Liu Y., Zhang J., et al. Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways. Physiol Genomics 2013, 45(16):710-719.
46. Sun G., Reddy M.A., Yuan H., et al. Epigenetic histone methylation modulates fibrotic gene expression. J Am Soc Nephrol 2010, 21(12):2069-2080.
47. Keating S.T., El-Osta A. Glycemic memories and the epigenetic component of diabetic nephropathy. Curr Diab Rep 2013, 13(4):574-581.
48. Yuan H., Reddy M.A., Sun G., et al. Involvement of p300/CBP and epigenetic histone acetylation in TGF-beta1-mediated gene transcription in mesangial cells. Am J Physiol Renal Physiol 2013, 304(5):F601-F613.
49. Reddy M.A., Sumanth P., Lanting L., et al. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Kidney Int 2014, 85(2):362-373.
50. Noh H., Oh E.Y., Seo J.Y., et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol 2009, 297(3):F729-F739.
51. Gaikwad A.B., Gupta J., Tikoo K. Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions. Biochem J 2010, 432(2):333-341.
52. Komers R., Mar D., Denisenko O., et al. Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes. Lab Invest 2013, 93(5):543-552.
53. Kato M., Zhang J., Wang M., et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 2007, 104(9):3432-3437.
54. Simmonds M.J., Benavente D., Brand O.J., et al. Skewing of female X-chromosome inactivation: an epigenetic risk factor for kidney transplantation outcome. Transplantation 2013, 95(5):e25-e28.
55. Kato M., Natarajan R. MicroRNA circuits in transforming growth factor-beta actions and diabetic nephropathy. Semin Nephrol 2012, 32(3):253-260.
56. Zhou Q., Chung A.C., Huang X.R., et al. Identification of novel long noncoding RNAs associated with TGF-beta/Smad3-mediated renal inflammation and fibrosis by RNA. Seq Am J Pathol 2014, 184(2):409-417.
57. Bell C.G., Teschendorff A.E., Rakyan V.K., et al. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 2010, 3:33.
58. McCaughan J.A., McKnight A.J., Courtney A.E., Maxwell A.P. Epigenetics: time to translate into transplantation. Transplantation 2012, 94(1):1-7.
59. Smyth L.J., McKay G.J., Maxwell A.P., McKnight A.J. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics 2014, 9(3):366-376.
60. Sapienza C., Lee J., Powell J., et al. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 2011, 6(1):20-28.
61. Young G.H., Wu V.C. KLOTHO methylation is linked to uremic toxins and chronic kidney disease. Kidney Int 2012, 81(7):611-612.
62. Ko Y.A., Mohtat D., Suzuki M., et al. Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol 2013, 14(10):R108.
63. Ong M.L., Holbrook J.D. Novel region discovery method for Infinium 450K DNA methylation data reveals changes associated with aging in muscle and neuronal pathways. Aging Cell 2014, 13(1):142-155.
64. Stenvinkel P., Karimi M., Johansson S., et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?. J Intern Med 2007, 261(5):488-499.
65. Brennan E.P., Ehrich M., O'Donovan H., et al. DNA methylation profiling in cell models of diabetic nephropathy. Epigenetics 2010, 5(5):396-401.
66. Reinius L.E., Acevedo N., Joerink M., et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012, 7(7):e41361.
67. Houseman E.A., Accomando W.P., Koestler D.C., et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 2012, 13:86.
68. Brennan E.P., Ehrich M., Brazil D.P., et al. Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines. Epigenetics 2009, 4(3):159-164.
69. Jacobsen S.C., Brons C., Bork-Jensen J., et al. Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia 2012, 55(12):3341-3349.
70. McKnight A.J., Maxwell A.P. Bioinformatic resources for diabetic nephropathy. J Diabetes Bioinformatics 2014, in press.
71. Grassi M.A., Tikhomirov A., Ramalingam S., et al. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 2011, 20(12):2472-2481.
72. Mooyaart A.L., Valk E.J., van Es L.A., et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 2011, 54(3):544-553.
73. Zhou T.B., Jiang Z.P., Qin Y.H., Drummen G.P. Association of transforming growth factor-beta1 T869C gene polymorphism with diabetic nephropathy risk. Nephrology 2014, 19(2):107-115.
74. Lin C., Yang H.Y., Wu C.C., et al. Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension-a meta-regression analysis of 98 observational studies. PLoS One 2014, 9(1):e87604.
75. Wang F., Fang Q., Yu N., et al. Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects. J Renin Angiotensin Aldosterone Syst 2012, 13(1):161-174.
76. Yin Y.W., Qiao L., Sun Q.Q., et al. Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies. Metabolism 2014, 63(4):532-541.
77. Li Y., Tang K., Zhang Z., et al. Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. Mol Biol Rep 2011, 38(5):3243-3252.
78. Kang P., Tian C., Jia C. Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy. Gene 2012, 500(1):1-9.
79. Niu W., Qi Y. An updated meta-analysis of methylenetetrahydrofolate reductase gene 677C/T polymorphism with diabetic nephropathy and diabetic retinopathy. Diabetes Res Clin Pract 2012, 95(1):110-118.
80. Ding W., Wang F., Fang Q., et al. Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy: a meta-analysis. Mol Biol Rep 2012, 39(2):1293-1303.
81. Maeda S., Araki S., Babazono T., et al. Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes 2010, 59(8):2075-2079.
82. McKnight A.J., Patterson C.C., Sandholm N., et al. Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysis. Am J Nephrol 2010, 32(5):476-481.
83. Zeng Z., Li L., Zhang Z., et al. A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy. Hum Genet 2010, 127(4):373-381.
84. Igo R.P., Iyengar S.K., Nicholas S.B., et al. Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol 2011, 33(5):381-389.